Weinberger M W, Harger J H
Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine, Madison.
Obstet Gynecol. 1993 Sep;82(3):425-9.
To assess the accuracy of Papanicolaou smears in reporting cytologic evidence of Trichomonas vaginalis in asymptomatic women attending a resident clinic.
In phase I of this study, we prospectively enrolled 100 asymptomatic gynecologic patients to be screened for vaginal trichomoniasis using wet preparation, vaginal culture, and Papanicolaou smear. During phase II, asymptomatic patients (40 gynecologic and 20 obstetric) whose screening Papanicolaou smears showed cytologic evidence of trichomoniasis returned for wet preparation, culture, and repeat Papanicolaou smear. Patients were considered infected with T vaginalis if either the wet preparation or culture was positive, and uninfected if both tests were negative. The cytopathologist was not informed of the patient's enrollment in this study or of the results of culture or wet preparation.
The prevalence of asymptomatic trichomonas infection in gynecologic patients enrolled in phase I was 6%. In asymptomatic gynecologic patients enrolled in phase II, repeat Papanicolaou smear had a sensitivity and specificity of 86 and 83%, respectively, when diagnosing infection. Thirty percent of these patients would have been treated unnecessarily for trichomoniasis based upon screening Papanicolaou smear. In obstetric patients, the sensitivity of repeat Papanicolaou smear was 94% and specificity was 100%. Had therapy been initiated based on screening cytology, 20% of obstetric patients would have received unindicated therapy. The differences in sensitivity and specificity between the groups were statistically significant (P < .05).
When a screening Papanicolaou smear reports cytologic evidence of T vaginalis infection in the asymptomatic patient, a confirmatory test should be performed before initiating therapy.
评估巴氏涂片在报告无症状女性滴虫性阴道炎细胞学证据方面的准确性,这些女性在一家住院诊所就诊。
在本研究的第一阶段,我们前瞻性招募了100名无症状妇科患者,使用湿片法、阴道培养和巴氏涂片筛查阴道毛滴虫病。在第二阶段,筛查巴氏涂片显示有滴虫病细胞学证据的无症状患者(40名妇科患者和20名产科患者)返回进行湿片法、培养和重复巴氏涂片检查。如果湿片法或培养呈阳性,则认为患者感染阴道毛滴虫;如果两项检查均为阴性,则认为未感染。细胞病理学家未被告知患者参与本研究的情况或培养或湿片法的结果。
第一阶段招募的妇科患者中无症状滴虫感染的患病率为6%。在第二阶段招募的无症状妇科患者中,重复巴氏涂片在诊断感染时的敏感性和特异性分别为86%和83%。基于筛查巴氏涂片,这些患者中有30%会因滴虫病接受不必要的治疗。在产科患者中,重复巴氏涂片的敏感性为94%,特异性为100%。如果根据筛查细胞学开始治疗,20%的产科患者会接受不必要的治疗。两组之间敏感性和特异性的差异具有统计学意义(P < 0.05)。
当筛查巴氏涂片报告无症状患者有阴道毛滴虫感染的细胞学证据时,在开始治疗前应进行确诊试验。